title: JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report.
authors.affiliation: Department of Hematology, University Hospital Basel, Basel, Switzerland. girsbergers@uhbs.ch
authors.forename: Sabine
authors.initials: S
authors.lastname: Girsberger
authors.forename: Axel
authors.initials: A
authors.lastname: Karow
authors.forename: Pontus
authors.initials: P
authors.lastname: Lundberg
authors.forename: Stephan
authors.initials: S
authors.lastname: Dirnhofer
authors.forename: Thomas
authors.initials: T
authors.lastname: Lehmann
authors.forename: Jakob R
authors.initials: JR
authors.lastname: Passweg
authors.forename: André
authors.initials: A
authors.lastname: Tichelli
authors.forename: Radek
authors.initials: R
authors.lastname: Skoda
authors.forename: Alicia
authors.initials: A
authors.lastname: Rovó
mesh_terms: D000483:Alleles; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019046:Bone Marrow Neoplasms / Q000175:diagnosis / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000627:therapeutic use; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000556:secondary
chemical_list: D000970:Antineoplastic Agents; D005047:Etoposide; D008942:Mitoxantrone; D053614:Janus Kinase 2